RTA 901 (BIIB143)

RTA 901 · Reata Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RTA 901 (BIIB143), covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain [Phase 2]